Participants 60 94 6
patients with head and neck cancer
Participants 164 204 4
patients with head and neck cancer (HNC)
Participants 399 432 6
patients with stage III or IV HNC
Participants 996 1087 4
471 patients in RTOG 0129 (2002 to 2005) with known human papillomavirus and smoking status
